J05AE30 Nirmatrelvir and ritonavir
ATC class of level 5 – chemical substance
This page lists the patient medication information or the product monograph for 2 drugs in this drug class.
- 2 prescription (Rx)
Place in the ATC system
- J Antiinfectives for systemic use 1,101 drugs
- J05 Antivirals for systemic use 246 drugs
- J05A Direct acting antivirals 246 drugs
- J05AE Protease inhibitors, direct acting antivirals 28 drugs
- J05AE30 Nirmatrelvir and ritonavir 2 drugs
- J05AE Protease inhibitors, direct acting antivirals 28 drugs
- J05A Direct acting antivirals 246 drugs
- J05 Antivirals for systemic use 246 drugs
Active ingredients of the class
- Nirmatrelvir 2 drugs
- Ritonavir 2 drugs
Drugs in the class
| Drug | Rx or OTC |
|---|---|
| Paxlovid (Pfizer Canada, PM 00081268) PM | prescription (Rx) |
| Paxlovid (Pfizer Canada, PM 00085971) PM | prescription (Rx) |
Other classes of the same level
- J05AE01 Saquinavir 1 drug
- J05AE02 Indinavir 2 drugs
- J05AE03 Ritonavir 4 drugs
- J05AE04 Nelfinavir 1 drug
- J05AE05 Amprenavir 2 drugs
- J05AE07 Fosamprenavir 1 drug
- J05AE08 Atazanavir 5 drugs
- J05AE09 Tipranavir 1 drug
- J05AE10 Darunavir 9 drugs
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class J05AE30
Ask your doctor or pharmacist for advice.